IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.856
NA - Nord America 3.632
AS - Asia 1.127
SA - Sud America 97
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 11
Totale 8.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.431
RU - Federazione Russa 1.218
IT - Italia 836
GB - Regno Unito 670
SG - Singapore 651
DE - Germania 428
UA - Ucraina 270
CA - Canada 191
HK - Hong Kong 157
VN - Vietnam 130
CN - Cina 129
DK - Danimarca 117
SE - Svezia 97
BR - Brasile 81
FR - Francia 69
FI - Finlandia 46
IE - Irlanda 40
PL - Polonia 15
NL - Olanda 12
EU - Europa 11
ID - Indonesia 10
IN - India 9
AT - Austria 6
BD - Bangladesh 6
AR - Argentina 5
IR - Iran 5
LT - Lituania 5
MA - Marocco 5
MX - Messico 5
BE - Belgio 4
CH - Svizzera 4
CO - Colombia 4
IQ - Iraq 4
PK - Pakistan 4
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
SM - San Marino 3
TH - Thailandia 3
TR - Turchia 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
JP - Giappone 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 8.738
Salva come PNG Salva come JPEG
Città #
Southend 444
Chandler 314
Singapore 297
Houston 290
Fairfield 252
Ann Arbor 241
Woodbridge 224
San Mateo 200
Seattle 141
Wilmington 140
Moscow 132
Cambridge 129
Falls Church 129
Hong Kong 129
Dearborn 108
Jacksonville 107
Ashburn 106
Ottawa 100
Boardman 92
Stevenage 79
Portsmouth 78
Pisa 71
Dong Ket 68
Beijing 63
Lawrence 57
Beauharnois 56
Rome 53
Milan 42
Dublin 38
The Dalles 35
Chicago 34
San Diego 34
Santa Clara 33
Los Angeles 31
Florence 23
Brooklyn 22
Central District 21
London 21
Montréal 21
Redwood City 21
Dallas 18
Salt Lake City 17
Buffalo 15
Helsinki 15
Palermo 14
Bari 13
Warsaw 13
Genoa 12
Munich 12
Padova 12
Elk Grove Village 11
Norwalk 11
Nuremberg 11
Napoli 10
Old Bridge 10
Salerno 10
Bologna 9
Fremont 9
Lucca 9
Tampa 9
Dongguan 8
Lappeenranta 8
Redmond 8
Toronto 8
Frankfurt am Main 7
Naples 7
Assago 6
Cascina 6
Grammichele 6
Guangzhou 6
Shanghai 6
Turin 6
Veglie 6
Pavia 5
Perugia 5
Reggio Calabria 5
Sterling 5
São Paulo 5
Wandsworth 5
Acton 4
Augusta 4
Brussels 4
Chiswick 4
Livorno 4
Lyon 4
Rio de Janeiro 4
Tehran 4
Venice 4
Agordo 3
Amman 3
Barletta 3
Campinas 3
Council Bluffs 3
Dulles 3
Fabriano 3
Ferrara 3
Honolulu 3
Hounslow 3
Mountain View 3
Nairobi 3
Totale 4.906
Salva come PNG Salva come JPEG
Nome #
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 598
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 237
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 211
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 202
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 201
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 198
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 196
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 195
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 187
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 183
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 178
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 177
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 176
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 172
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 171
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 171
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 170
Update sui biomarcatori nello scompenso cardiaco. 169
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 167
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 161
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 157
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 151
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 149
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 145
A simple echocardiographic score to rule out cardiac amyloidosis 143
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 141
Sex-related differences in chronic heart failure 140
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 124
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 122
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 110
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 105
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 104
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 95
Troponin in non-ischaemic dilated cardiomyopathy 93
A simple echocardiographic score to rule out cardiac amyloidosis 91
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 90
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 88
Cardiovascular disease and COVID-19: les liaisons dangereuses 84
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 83
Molecular autopsy of sudden cardiac death in the genomics era 81
Role of Imaging in Cardiomyopathies 80
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 80
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 78
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 78
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 78
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 77
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 75
Treatment of cardiac transthyretin amyloidosis: an update 74
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 74
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 73
Cardiac magnetic resonance in patients with muscular dystrophies 73
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 73
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 71
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 69
Colchicine for the treatment of coronary artery disease 66
Valvular heart disease in patients with cardiac amyloidosis 64
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 64
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 63
The Barthel Index in elderly acute heart failure patients. Frailty matters 63
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 62
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 59
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 56
The unbearable underreporting of comorbidities in heart failure clinical trials 53
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 50
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 48
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 48
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 48
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 45
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 44
Partial Lipodystrophy and LMNA p.R545H Variant 44
Perspectives in noninvasive imaging for chronic coronary syndromes 44
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 44
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 43
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 43
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 42
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 42
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 40
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 38
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 34
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 34
null 29
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 26
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 24
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 22
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 15
Totale 8.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 0 0 0 0 0 21 23 73
2020/20211.519 110 120 54 114 96 179 136 74 160 112 171 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20252.813 45 54 208 67 166 214 505 970 327 257 0 0
Totale 8.866